ProFibrix's Acquisition

ProFibrix was acquired by The Medicines Company on August 06, 2013.

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting …

Articles about ProFibrix's Acquisition: